
Jason Beaubien
Jason Beaubien is NPR's Global Health and Development Correspondent on the Science Desk.
In this role, he reports on a range of issues across the world. He's covered the plight of Rohingya refugees in Bangladesh, mass cataract surgeries in Ethiopia, abortion in El Salvador, poisonous gold mines in Nigeria, drug-resistant malaria in Myanmar and tuberculosis in Tajikistan. He was part of a team of reporters at NPR that won a Peabody Award in 2015 for their extensive coverage of the West Africa Ebola outbreak. His current beat also examines development issues including why Niger has the highest birth rate in the world, can private schools serve some of the poorest kids on the planet and the links between obesity and economic growth.
Prior to becoming the Global Health and Development Correspondent in 2012, Beaubien spent four years based in Mexico City covering Mexico, Central America and the Caribbean. In that role, Beaubien filed stories on politics in Cuba, the 2010 Haitian earthquake, the FMLN victory in El Salvador, the world's richest man and Mexico's brutal drug war.
For his first multi-part series as the Mexico City correspondent, Beaubien drove the length of the U.S./Mexico border making a point to touch his toes in both oceans. The stories chronicled the economic, social and political changes along the violent frontier.
In 2002, Beaubien joined NPR after volunteering to cover a coup attempt in the Ivory Coast. Over the next four years, Beaubien worked as a foreign correspondent in sub-Saharan Africa, visiting 27 countries on the continent. His reporting ranged from poverty on the world's poorest continent, the HIV in the epicenter of the epidemic, and the all-night a cappella contests in South Africa, to Afro-pop stars in Nigeria and a trial of white mercenaries in Equatorial Guinea.
During this time, he covered the famines and wars of Africa, as well as inspiring preachers and Nobel laureates. Beaubien was one of the first journalists to report on the huge exodus of people out of Sudan's Darfur region into Chad, as villagers fled some of the initial attacks by the Janjawid. He reported extensively on the steady deterioration of Zimbabwe and still has a collection of worthless Zimbabwean currency.
In 2006, Beaubien was awarded a Knight-Wallace fellowship at the University of Michigan to study the relationship between the developed and the developing world.
Beaubien grew up in Maine, started his radio career as an intern at NPR Member Station KQED in San Francisco and worked at WBUR in Boston before joining NPR.
-
Though optimism grows in the U.S. as more and more people get vaccinated, the global picture is far from rosy. Several countries are struggling, and things continue to look grim.
-
The European Medicines Agency concluded there is a possible link between the Johnson & Johnson vaccine and rare, unusual blood clots, saying the benefits of the vaccine outweigh the very rare risks.
-
The European Medicines Agency says there is a possible link between the J&J vaccine and rare blood clotting. It says a warning should be added to the label, but says benefits outweigh the risks.
-
The U.S. Food and Drug Administration's decision to temporarily halt the use of the Johnson & Johnson COVID-19 vaccine is having ramifications globally.
-
Rare, but potentially fatal blood clots linked to the AstraZeneca vaccine has lead to several countries limiting its use in young people. It's a vaccine many countries are depending on.
-
The European Medicines Agency says there is a possible link between the AstraZeneca COVID vaccine and rare blood clots.
-
Some countries have made great strides in vaccinating their populations, but much of the world has made hardly any headway. Countries with excess vaccine stockpiles could loan doses to those in need.
-
The agency's conclusion comes as the Biden administration announced it would send AstraZeneca vaccines to Canada and Mexico.
-
More European countries are suspending use of the AstraZeneca COVID-19 vaccine after reports that some recipients developed blood clots. The vaccine is not authorized in the United States.
-
The Prime Minister of Trinidad and Tobago gave an impassioned speech about the vaccine rollout, warning of hoarding and price gouging. Here's what we could find out about the cost of a dose.